Kiernan M - Search Results

1

Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.

Talman P, Duong T, Vucic S, Mathers S, Venkatesh S, Henderson R, Rowe D, Schultz D, Edis R, Needham M, Macdonnell R, McCombe P, Birks C, Kiernan M. Talman P, et al. Among authors: kiernan m. BMJ Open. 2016 Sep 30;6(9):e012054. doi: 10.1136/bmjopen-2016-012054. BMJ Open. 2016. PMID: 27694488 Free PMC article.

2

Assessment of disease progression in motor neuron disease.

Winhammar JM, Rowe DB, Henderson RD, Kiernan MC. Winhammar JM, et al. Among authors: kiernan mc. Lancet Neurol. 2005 Apr;4(4):229-38. doi: 10.1016/S1474-4422(05)70042-9. Lancet Neurol. 2005. PMID: 15778102 Review.

3

Assessment of cortical excitability using threshold tracking techniques.

Vucic S, Howells J, Trevillion L, Kiernan MC. Vucic S, et al. Muscle Nerve. 2006 Apr;33(4):477-86. doi: 10.1002/mus.20481. Muscle Nerve. 2006. PMID: 16315324 Clinical Trial.

4

Riluzole therapy for motor neurone disease: an early Australian experience (1996-2002).

Zoing MC, Burke D, Pamphlett R, Kiernan MC. Zoing MC, et al. J Clin Neurosci. 2006 Jan;13(1):78-83. doi: 10.1016/j.jocn.2004.04.011. J Clin Neurosci. 2006. PMID: 16410201 Clinical Trial.

5

Establishment of an Australian motor neurone disease registry.

Kiernan MC, Talman P, Henderson RD, Harris R; AMNDR Steering Committee. Kiernan MC, et al. Med J Aust. 2006 Apr 3;184(7):367-8. doi: 10.5694/j.1326-5377.2006.tb00279.x. Med J Aust. 2006. PMID: 16584377 No abstract available.

6

Axonal excitability properties in amyotrophic lateral sclerosis.

Vucic S, Kiernan MC. Vucic S, et al. Clin Neurophysiol. 2006 Jul;117(7):1458-66. doi: 10.1016/j.clinph.2006.04.016. Epub 2006 Jun 8. Clin Neurophysiol. 2006. PMID: 16759905

7

Nocturnal hypoxia in motor neuron disease is not predicted by standard respiratory function tests.

Winhammar JM, Joffe D, Simmul R, Schoeffel R, Kiernan MC, Rowe DB. Winhammar JM, et al. Among authors: kiernan mc. Intern Med J. 2006 Jul;36(7):419-22. doi: 10.1111/j.1445-5994.2006.01102.x. Intern Med J. 2006. PMID: 16780447

8

Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.

Vucic S, Kiernan MC. Vucic S, et al. Brain. 2006 Sep;129(Pt 9):2436-46. doi: 10.1093/brain/awl172. Epub 2006 Jul 10. Brain. 2006. PMID: 16835248

9

Hyperimmune goat serum for amyotrophic lateral sclerosis.

Mackenzie R, Kiernan M, McKenzie D, Youl BD. Mackenzie R, et al. Among authors: kiernan m. J Clin Neurosci. 2006 Dec;13(10):1033-6. doi: 10.1016/j.jocn.2006.03.009. Epub 2006 Sep 22. J Clin Neurosci. 2006. PMID: 16996272

10

Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis.

Vucic S, Kiernan MC. Vucic S, et al. J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):849-52. doi: 10.1136/jnnp.2006.105056. Epub 2007 Jan 8. J Neurol Neurosurg Psychiatry. 2007. PMID: 17210625 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,065 results

Search Page

Filters